The Economic Times

TDI Infratech to invest Rs 75 cr in upcoming Ramada hotel in Haryana

• The Economic Times

TDI Infratech to invest Rs 75 cr in upcoming Ramada hotel in Haryana

Aris June 16, 2026

TDI Infratech is pouring Rs 75 crore into an opulent hotel project in Panipat, Haryana, set to...

Read More Read more about TDI Infratech to invest Rs 75 cr in upcoming Ramada hotel in Haryana

Pidilite Industries among 4 commodities stocks that hit 52-week highs and rallied up to 65% in a month

• The Economic Times

Pidilite Industries among 4 commodities stocks that hit 52-week highs and rallied up to 65% in a month

Aris June 16, 2026

Deccan Gold Mines, Sudeep Pharma, Neogen Chemicals and Pidilite Industries touched fresh 52-week highs as the Sensex...

Read More Read more about Pidilite Industries among 4 commodities stocks that hit 52-week highs and rallied up to 65% in a month

Infrastructure Investment Trusts distribute Rs 22,800cr in FY26 to unitholders

• The Economic Times

Infrastructure Investment Trusts distribute Rs 22,800cr in FY26 to unitholders

Aris June 16, 2026

Infrastructure Investment Trusts distributed nearly Rs 22,800 crore to unitholders last fiscal. Assets Under Management grew to...

Read More Read more about Infrastructure Investment Trusts distribute Rs 22,800cr in FY26 to unitholders

Arvind SmartSpaces eyes Rs 180 cr revenue from housing project in Ahmedabad

• The Economic Times

Arvind SmartSpaces eyes Rs 180 cr revenue from housing project in Ahmedabad

Aris June 16, 2026

Arvind SmartSpaces Ltd is embarking on a new chapter in Ahmedabad by partnering with a landowner for...

Read More Read more about Arvind SmartSpaces eyes Rs 180 cr revenue from housing project in Ahmedabad

Rupee closes at 94.56 vs USD; US-Iran peace agreement details, Fed guidance awaited

• The Economic Times

Rupee closes at 94.56 vs USD; US-Iran peace agreement details, Fed guidance awaited

Aris June 16, 2026

The Indian rupee strengthened for the third day in a row. This rise was supported by positive...

Read More Read more about Rupee closes at 94.56 vs USD; US-Iran peace agreement details, Fed guidance awaited

InvIT market expands with new listings; cumulative distributions top Rs 91,000 crore

• The Economic Times

InvIT market expands with new listings; cumulative distributions top Rs 91,000 crore

Aris June 16, 2026

India’s InvIT sector recorded strong growth in FY26, with Rs 7,719 crore distributed in Q4 alone and...

Read More Read more about InvIT market expands with new listings; cumulative distributions top Rs 91,000 crore

Liotech Industries Rs 36-cr IPO to open on Wednesday

• The Economic Times

Liotech Industries Rs 36-cr IPO to open on Wednesday

Aris June 16, 2026

Liotech Industries is launching its Rs 36 crore initial public offering on June 17. The bidding will...

Read More Read more about Liotech Industries Rs 36-cr IPO to open on Wednesday

IPO: 23 firms launch public issues worth Rs 27,000 cr in 2026; 236 proposals remain in pipeline

• The Economic Times

IPO: 23 firms launch public issues worth Rs 27,000 cr in 2026; 236 proposals remain in pipeline

Aris June 16, 2026

India’s IPO market saw a slowdown in 2026 following a robust 2025. However, activity is picking up...

Read More Read more about IPO: 23 firms launch public issues worth Rs 27,000 cr in 2026; 236 proposals remain in pipeline

World’s 500 richest add record $336 billion to wealth in one day

• The Economic Times

World’s 500 richest add record $336 billion to wealth in one day

Aris June 16, 2026

The world’s richest saw a massive gain of $336 billion on June 15. Elon Musk’s wealth surged...

Read More Read more about World’s 500 richest add record $336 billion to wealth in one day

Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan Kulkarni

• The Economic Times

Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan Kulkarni

Aris June 16, 2026

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new...

Read More Read more about Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan Kulkarni